BioNTech Stock Pops Again — Covid Jab Proves 100% Effective In Teenagers

Pfizer and BioNTech said Wednesday their Covid-19 shots were 100% effective in adolescents ages 12-15 years old — leading BioNTech stock to surge for a second day running.
Read More